Cerebellar Involvement in Attacks of Aquaporin-4-IgG Positive Neuromyelitis Optica Spectrum Disorder
Cerebellar involvement during attacks of AQP4+NMOSD is rare but the associated neurologic deficits tend to be severe. Cerebellar peduncle or dentate nucleus T2-lesions are frequent MRI accompaniments. Clinical features and MRI lesion patterns of cerebellar involvement could be incorporated into future iterations of AQP4+NMOSD criteria.
Authors
- Dean M. Wingerchuk (ORCID: https://orcid.org/0000-0003-1608-8206)
- Laura Cacciaguerra (ORCID: https://orcid.org/0000-0001-9342-2410)
- A. Sebastian López‐Chiriboga (ORCID: https://orcid.org/0000-0001-5653-5600)
- Eoin P. Flanagan (ORCID: https://orcid.org/0000-0002-6661-2910)
- Brian G. Weinshenker (ORCID: https://orcid.org/0000-0001-5806-6203)
- Cristina Valencia-Sánchez (ORCID: https://orcid.org/0000-0003-0116-8035)
- Alessandro Dinoto (ORCID: https://orcid.org/0000-0002-3249-4792)
- Karl N. Krecke (ORCID: https://orcid.org/0000-0003-1950-5589)
- John Jing-Wei Chen (ORCID: https://orcid.org/0000-0003-3644-7528)
- Elia Sechi (ORCID: https://orcid.org/0000-0003-4698-663X)
- Sean Joseph Pittock (ORCID: https://orcid.org/0000-0002-6140-5584)
- Samantha A. Banks (ORCID: https://orcid.org/0000-0002-5856-1367)
Institutions
- Mayo Clinic in Arizona (US)
Publication Details
- Journal
- Neurology Neuroimmunology & Neuroinflammation
- Published
- 2024-12-11
- DOI
- https://doi.org/10.1212/nxi.0000000000200344
- Citations
- 2
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.85
Funders
- Bristol-Myers Squibb
- AstraZeneca
- Sanofi
- Alexion Pharmaceuticals
- Celgene
- Horizon Therapeutics
- University of Oxford
- Hospices Civils de Lyon
- Grifols
- National Institutes of Health
- Genentech